Epstein Secrets

ders." Senate Panel Approves Wolf For DHS Post. The Washington Times (9/30, Dinan, 492K) reports a Senate panel gave initial approval Wednesday to Chad Wolf, President Trump's pick to lead DHS, "with Republicans brushing aside complaints from immigrant-rights groups to power the nomination to the Senate

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

ders." Senate Panel Approves Wolf For DHS Post. The Washington Times (9/30, Dinan, 492K) reports a Senate panel gave initial approval Wednesday to Chad Wolf, President Trump's pick to lead DHS, "with Republicans brushing aside complaints from immigrant-rights groups to power the nomination to the Senate

nsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

ders." Senate Panel Approves Wolf For DHS Post. The Washington Times (9/30, Dinan, 492K) reports a Senate panel gave initial approval Wednesday to Chad Wolf, President Trump's pick to lead DHS, "with Republicans brushing aside complaints from immigrant-rights groups to power the nomination to the Senate

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v